Neuropsychologic effects of chemotherapy on children with cancer: A longitudinal study

Journal of Clinical Oncology

Volumn 14, Issue 10, 1996, Pages 2826-2835

  Copeland, D R ^a   Moore III, B D ^a   Francis, D J ^a   Jaffe, N ^a   Culbert, S J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD PSYCHOLOGY; CHILDHOOD CANCER; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PERCEPTION; PRIORITY JOURNAL; SKULL IRRADIATION; SOCIOECONOMICS; TREATMENT OUTCOME;

EID: 0029739176     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.10.2826     Document Type: Article

References (64)

1. Boring CC, Squires TS, Tong T, et al: Cancer statistics. CA Cancer J Clin 44:7-26, 1994
2. Fletcher JM, Copeland DR: Neurobehavioral effects of central nervous system prophylactic treatment of cancer in children. J Clin Exp Neuropsychol 10:495-538, 1988
3. Cousens P, Waters S, Said J, et al: Cognitive effects of cranial irradiation in leukemia: A survey and meta-analysis. J Child Psychol Psychiatry 29:839-852, 1988
4. Packer RJ, Meadows AT, Rorke LB, et al: Long-term sequelae of cancer treatment on the central nervous system in childhood. Med Pediatr Oncol 15:241-253, 1987
5. Stehbens JA, Kaleita TA, Noll RB, et al: CNS prophylaxis of childhood leukemia: What are the long-term neurological, neuropsy-chological, and behavioral effects? Neuropsych Rev 2:147-177, 1991
6. Hollingshead AB: Two Factor Index of Social Position. New Haven, CT, Yale University Press, 1957
7. McCarthy D: Manual for the McCarthy Scales of Children's Abilities. New York. NY, Psychological Corp, 1972
8. Wechsler D: Manual for the Wechsler Intelligence Scale for Children-Revised. New York, NY, Psychological Corp, 1974
9. Wechsler D: Manual for the Wechsler Adult Intelligence Scale. New York, NY, Psychological Corp, 1955
10. Jastak JF, Jastak S: Wide Range Achievement Test (revised). Wilmington, DE, Jastak Associates, 1978
11. Dunn LM, Markwardt FC: Peabody Individual Achievement Test. Circle Pines, MN, American Guidance Service, 1970
12. Dunn LM, Dunn LM: Peabody Picture Vocabulary Test, Revised. Circle Pines, MN, American Guidance Service, 1981
13. Buschke H: Components of verbal learning in children: Analysis by selective reminding. J Exp Child Psychol 18:488-496, 1974
14. Fletcher JM: Memory for verbal and nonverbal stimuli in learning disabled subgroups: Analysis by selective reminding. J Exp Child Psychol 40:244-259, 1985
15. Sattler JM: Assessment of Children (ed 3). San Diego, CA, Jerome M. Sattler, 1988
16. Gaddes WH, Crockett DJ: The Spreen-Benton Aphasic Tests: Normative data as a measure of normal language development. Brain Lang 2:257-259, 1975
17. Reitan R: Manual for Administration of Neuropsychological Test Batteries on Adults and Children. Bloomington, IN, Indiana University Press, 1969
18. Trites RL: Neuropsychological Test Manual. Ottawa, Canada, Royal Ottawa Hospital, 1977
19. Beery K, Buktenika N: Developmental Test of Visual-Motor Integration. Chicago, IL, Follett Education Co, 1967
20. Benton AL, Hansher K, Varney NR, et al: Contributions to Neuropsychological Assessment. Cary, NC, Oxford University Press, 1983
21. Bray J, Maxwell S: Analyzing and interpreting significant MANOVAs. Rev Educ Res 52:340-367, 1982
22. Pinkel D, Woo S: Prevention and treatment of meningeal leukemia in children. Blood 84:355-366, 1994
23. Pullen J, Boyett J, Shuster J, et al: Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol 11:839-849, 1993
24. Sullivan MP, Chen T, Dyment PG, et al: Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: A Pediatric Oncology Group study. Blood 60:948-958, 1982
25. Tubergen DG, Gilchrist GS, O'Brien RT, et al: Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: A Children's Cancer Group phase III trial. J Clin Oncol 11:527-545, 1993
26. +) acute lymphoblastic leukemia (BALL) and stage IV small noncleaved cell lymphomas (SNCCL). Proc Am Soc Clin Oncol 11:277, 1992 (abstr 919)
27. Littman P, Coccia P, Bleyer WA, et al: Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL). Int J Radiat Oncol Biol Phys 13:1443-1449, 1987
28. Rivera GK, Raimondi SC, Hancock ML, et al: Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 337:61-66, 1991
29. Krance RA, Newman EM, Ravindranath Y, et al: A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non T, non B acute lymphoblastic leukemia. A Pediatric Oncology Group study. Cancer 67:550-556, 1991
30. Camitta B, Lauer S, Leventhal B, et al: Early intensive methotrexate (MTX)/6-mercaptopurine (MP) for higher risk childhood acute lymphocytic leukemia (ALL): A Pediatric Oncology Group (POG) pilot study. Proc Am Soc Clin Oncol 11:280, 1992 (abstr 930)
31. Schwenn MR, Blattner SR, Lynch E, et al: HiC-COM: A 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol 9:133-138, 1991
32. Reiter A, Schrappe M, Ludwig WD, et al: Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM Group. Blood 80:2471-2478, 1992
33. Patte C, Philip T, Rodary C, et al: High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9:123-132, 1991
34. Soni SS, Marten GW, Pitner SE, et al: Effects of central nervous-system irradiation on neuropsychologic functioning of children with acute lymphocytic leukemia. N Engl J Med 293:113-118, 1975
35. Obetz SW, Smithson WA, Groover RV, et al: Neuropsycho logic follow-up study of children with acute lymphocytic leukemia: A preliminary report. Am J Pediatr Hematol Oncol 1:207-213, 1979
36. Ivnik RJ, Colligan RC, Obetz SW, et al: Neuropsychologic performance among children in remission from acute lymphocytic leukemia. J Dev Behav Pediatr 2:29-34, 1981
37. Moss HA, Nannis ED, Poplack DG: The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. Am J Med 7:47-52, 1981
38. Tamaroff M, Miller DR, Murphy ML, et al: Immediate and long-term post therapy neuropsychologic performance in children with acute lymphoblastic leukemia treated without central nervous system radiation. J Pediatr 101:524-529, 1982
39. Tamaroff M, Salwen R, Miller DR, et al: Comparison of post therapy neuropsychologic performance (NP) in irradiated and nonirradiated children with acute lymphoblastic leukemia (ALL). Proc Am Soc Clin Oncol 2:79, 1983 (abstr C-308)
40. Tamaroff M, Salwen R, Miller DR, et al: Comparison of neuropsychologic performance in children treated for acute lymphoblastic leukemia (ALL) with 1800 rads cranial radiation plus intrathecal methotrexate or intrathecal methotrexate alone. Proc Am Soc Clin Oncol 3:198, 1984 (abstr 773)
41. Tamaroff M, Salwen R, Miller DR, et al: Neuropsychologic sequelae in irradiated (1800 rads (r) & 2400 r) and non-irradiated children with acute lymphoblastic leukemia (ALL). Proc Am Soc Clin Oncol 4:165, 1985 (abstr C-644)
42. Pavlovsky S, Castrano J, Leiguarda R, et al: Neuropsychological study in patients with ALL. Two different CNS prevention therapies - Cranial irradiation plus IT methotrexate vs. IT methotrexate alone. Am J Pediatr Hematol Oncol 5:79-86, 1983
43. Rowland JH, Glidewell OJ, Sibley RF, et al: Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. J Clin Oncol 12:1327-1355, 1984
44. Pfefferbaum-Levine B, Copeland DR, Fletcher JM, et al: Neuropsychologic assessment of long-term survivors of childhood leukemia. Am J Pediatr Hematol Oncol 6:123-128, 1984
45. Whitt JK, Wells RJ, Lauria MM, et al: Cranial radiation in childhood acute lymphocytic leukemia. Am J Dis Child 138:730-736, 1984
46. Lansky SB, Cairns NU, Lansky LL, et al. Central nervous system prophylaxis: Studies showing impairment in verbal skills and academic achievement. Am J Pediatr Hematol Oncol 6:183-190, 1984
47. Copeland DR, Fletcher JM, Pfefferbaum-Levine B, et al: Neuropsychological sequelae of childhood cancer in long-term survivors. Pediatrics 75:745-753, 1985
48. Copeland DR, Dowell RE, Fletcher JM, et al: Neuropsychological effects of childhood cancer treatment. J Child Neurol 3:53-62, 1988
49. Copeland DR, Dowell RE, Fletcher JM, et al: Neuropsychological test performance of pediatric cancer patients at diagnosis and one year later. J Pediatr Psychol 13:183-196, 1988
50. Ochs J, Mulhern R, Fairclough D, et al: Comparison of neuropsychologic functioning and clinical neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: A prospective study. J Clin Oncol 9:145-151, 1991
51. Mulhern RK, Wasserman AL, Fairclough D, et al: Memory function in disease-free survivors of childhood acute lymphocytic leukemia given CNS prophylaxis with or without 1,800 cGy cranial irradiation. J Clin Oncol 6:315-320, 1988
52. Mulhern RK, Fairclough D, Ochs J: A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, or no cranial irradiation. J Clin Oncol 9:1348-1356, 1991
53. Mulhern RK, Ochs J, Fairclough D: Deterioration of intellect among children surviving leukemia: IQ test changes modify estimates of treatment toxicity. J Consult Clin Psychol 60:477-480, 1992
54. Schlieper AE, Esseltine DW, Tarshis MA: Cognitive function in long-term survivors of childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 6:1-9, 1989
55. Dowell RE Jr, Copeland DR, Judd BW: Neuropsychological effects of chemotherapeutic agents. J Dev Neuropsychol 5:17-24, 1989
56. Dowell RE Jr, Copeland DR, Francis DJ, et al: Absence of synergistic effects of CNS treatments on neuropsychological test performance among children. J Clin Oncol 9:1029-1036, 1991
57. Brown RT, Madan-Swain A, Pais R: Chemotherapy for acute lymphocytic leukemia: Cognitive and academic sequelae. J Pediatr 121:885-889, 1992
58. Butler RW, Hill JM, Steinherz PG, et al: Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol 12:2621-2629, 1994
59. Stehbens JA, MacLean WE, Kaleita TA, et al: Effects of CNS prophylaxis on the neuropsychological performance of children with acute lymphoblastic leukemia: Nine months postdiagnosis. Child Health Care 23:231-250, 1994
60. Robison LL, Nesbit ME, Sather HN, et al: Factors associated with IQ scores in long-term survivors of childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 6:115-121, 1984
61. Schlieper AE, Esseltine DW, Tarshis MA: Cognitive function in long-term survivors of childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 6:1-9, 1989
62. Waber DP, Urion DK, Tarbell NJ, et al: Late effects of central nervous system treatment of acute lymphoblastic leukemia in childhood are sex-dependent. Dev Med Child Neurol 32:238-248, 1990
63. Bleyer WA, Fallavollita J, Robison I, et al: Influence of age, sex and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood: A report from the Children's Cancer Study Group. Pediatr Hematol Oncol 7:329-338, 1990
64. Francis DJ, Copeland DR, Moore BD: Neuropsychological changes in children with cancer: The treatment of missing data in longitudinal studies. Neuropsychol Rev 4:499-522, 1994